The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Vascular Stents-Global Market Insights and Sales Trends 2024
Synopsis
The global Vascular Stents market size is expected to reach US$ 23380 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Vascular Stents in various end use industries. The expanding demands from the Hospitals & Cardiac Centers and Ambulatory Surgical Centers, are propelling Vascular Stents market. Bare-Metal Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug-Eluting Stents segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vascular Stents market, driven by demand from China, the second largest economy with some signs of stabilising, the Vascular Stents market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vascular Stents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vascular Stents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vascular Stents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vascular Stents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vascular Stents covered in this report include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se & Co. Kg, B. Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd. and Vascular Concepts Limited, etc.
The global Vascular Stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
B. Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard, Inc.
W.L. Gore and Associates, Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh
Global Vascular Stents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vascular Stents market, Segment by Type:
Bare-Metal Stents
Drug-Eluting Stents
Bioabsorbable Stents
Global Vascular Stents market, by Application
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vascular Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vascular Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
The global Vascular Stents market size is expected to reach US$ 23380 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is mainly driven by the significant applications of Vascular Stents in various end use industries. The expanding demands from the Hospitals & Cardiac Centers and Ambulatory Surgical Centers, are propelling Vascular Stents market. Bare-Metal Stents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Drug-Eluting Stents segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vascular Stents market, driven by demand from China, the second largest economy with some signs of stabilising, the Vascular Stents market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vascular Stents, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vascular Stents market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vascular Stents market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vascular Stents sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vascular Stents covered in this report include Medtronic Plc, Abbott Laboratories, Boston Scientific Corporation, Biotronik Se & Co. Kg, B. Braun Melsungen Ag, Terumo Corporation, Microport Scientific Corporation, Meril Life Sciences Pvt. Ltd. and Vascular Concepts Limited, etc.
The global Vascular Stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic Plc
Abbott Laboratories
Boston Scientific Corporation
Biotronik Se & Co. Kg
B. Braun Melsungen Ag
Terumo Corporation
Microport Scientific Corporation
Meril Life Sciences Pvt. Ltd.
Vascular Concepts Limited
C.R. Bard, Inc.
W.L. Gore and Associates, Inc.
Endologix, Inc.
Lombard Medical
Translumina Gmbh
Jotec Gmbh
Global Vascular Stents market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vascular Stents market, Segment by Type:
Bare-Metal Stents
Drug-Eluting Stents
Bioabsorbable Stents
Global Vascular Stents market, by Application
Hospitals & Cardiac Centers
Ambulatory Surgical Centers
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vascular Stents manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vascular Stents in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Vascular Stents Market Overview
1.1 Vascular Stents Product Overview
1.2 Vascular Stents Market Segment by Type
1.2.1 Bare-Metal Stents
1.2.2 Drug-Eluting Stents
1.2.3 Bioabsorbable Stents
1.3 Global Vascular Stents Market Size by Type
1.3.1 Global Vascular Stents Market Size Overview by Type (2018-2029)
1.3.2 Global Vascular Stents Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vascular Stents Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vascular Stents Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vascular Stents Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vascular Stents Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vascular Stents Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vascular Stents Sales Breakdown by Type (2018-2023)
2 Global Vascular Stents Market Competition by Company
2.1 Global Top Players by Vascular Stents Sales (2018-2023)
2.2 Global Top Players by Vascular Stents Revenue (2018-2023)
2.3 Global Top Players by Vascular Stents Price (2018-2023)
2.4 Global Top Manufacturers Vascular Stents Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vascular Stents Market Competitive Situation and Trends
2.5.1 Vascular Stents Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vascular Stents Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vascular Stents as of 2022)
2.7 Date of Key Manufacturers Enter into Vascular Stents Market
2.8 Key Manufacturers Vascular Stents Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vascular Stents Status and Outlook by Region
3.1 Global Vascular Stents Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vascular Stents Historic Market Size by Region
3.2.1 Global Vascular Stents Sales in Volume by Region (2018-2023)
3.2.2 Global Vascular Stents Sales in Value by Region (2018-2023)
3.2.3 Global Vascular Stents Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vascular Stents Forecasted Market Size by Region
3.3.1 Global Vascular Stents Sales in Volume by Region (2024-2029)
3.3.2 Global Vascular Stents Sales in Value by Region (2024-2029)
3.3.3 Global Vascular Stents Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vascular Stents by Application
4.1 Vascular Stents Market Segment by Application
4.1.1 Hospitals & Cardiac Centers
4.1.2 Ambulatory Surgical Centers
4.2 Global Vascular Stents Market Size by Application
4.2.1 Global Vascular Stents Market Size Overview by Application (2018-2029)
4.2.2 Global Vascular Stents Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vascular Stents Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vascular Stents Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vascular Stents Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vascular Stents Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vascular Stents Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vascular Stents Sales Breakdown by Application (2018-2023)
5 North America Vascular Stents by Country
5.1 North America Vascular Stents Historic Market Size by Country
5.1.1 North America Vascular Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vascular Stents Sales in Volume by Country (2018-2023)
5.1.3 North America Vascular Stents Sales in Value by Country (2018-2023)
5.2 North America Vascular Stents Forecasted Market Size by Country
5.2.1 North America Vascular Stents Sales in Volume by Country (2024-2029)
5.2.2 North America Vascular Stents Sales in Value by Country (2024-2029)
6 Europe Vascular Stents by Country
6.1 Europe Vascular Stents Historic Market Size by Country
6.1.1 Europe Vascular Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vascular Stents Sales in Volume by Country (2018-2023)
6.1.3 Europe Vascular Stents Sales in Value by Country (2018-2023)
6.2 Europe Vascular Stents Forecasted Market Size by Country
6.2.1 Europe Vascular Stents Sales in Volume by Country (2024-2029)
6.2.2 Europe Vascular Stents Sales in Value by Country (2024-2029)
7 Asia-Pacific Vascular Stents by Region
7.1 Asia-Pacific Vascular Stents Historic Market Size by Region
7.1.1 Asia-Pacific Vascular Stents Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vascular Stents Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vascular Stents Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vascular Stents Forecasted Market Size by Region
7.2.1 Asia-Pacific Vascular Stents Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vascular Stents Sales in Value by Region (2024-2029)
8 Latin America Vascular Stents by Country
8.1 Latin America Vascular Stents Historic Market Size by Country
8.1.1 Latin America Vascular Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vascular Stents Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vascular Stents Sales in Value by Country (2018-2023)
8.2 Latin America Vascular Stents Forecasted Market Size by Country
8.2.1 Latin America Vascular Stents Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vascular Stents Sales in Value by Country (2024-2029)
9 Middle East and Africa Vascular Stents by Country
9.1 Middle East and Africa Vascular Stents Historic Market Size by Country
9.1.1 Middle East and Africa Vascular Stents Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vascular Stents Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vascular Stents Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vascular Stents Forecasted Market Size by Country
9.2.1 Middle East and Africa Vascular Stents Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vascular Stents Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Medtronic Plc
10.1.1 Medtronic Plc Company Information
10.1.2 Medtronic Plc Introduction and Business Overview
10.1.3 Medtronic Plc Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Medtronic Plc Vascular Stents Products Offered
10.1.5 Medtronic Plc Recent Development
10.2 Abbott Laboratories
10.2.1 Abbott Laboratories Company Information
10.2.2 Abbott Laboratories Introduction and Business Overview
10.2.3 Abbott Laboratories Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Abbott Laboratories Vascular Stents Products Offered
10.2.5 Abbott Laboratories Recent Development
10.3 Boston Scientific Corporation
10.3.1 Boston Scientific Corporation Company Information
10.3.2 Boston Scientific Corporation Introduction and Business Overview
10.3.3 Boston Scientific Corporation Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Boston Scientific Corporation Vascular Stents Products Offered
10.3.5 Boston Scientific Corporation Recent Development
10.4 Biotronik Se & Co. Kg
10.4.1 Biotronik Se & Co. Kg Company Information
10.4.2 Biotronik Se & Co. Kg Introduction and Business Overview
10.4.3 Biotronik Se & Co. Kg Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Biotronik Se & Co. Kg Vascular Stents Products Offered
10.4.5 Biotronik Se & Co. Kg Recent Development
10.5 B. Braun Melsungen Ag
10.5.1 B. Braun Melsungen Ag Company Information
10.5.2 B. Braun Melsungen Ag Introduction and Business Overview
10.5.3 B. Braun Melsungen Ag Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.5.4 B. Braun Melsungen Ag Vascular Stents Products Offered
10.5.5 B. Braun Melsungen Ag Recent Development
10.6 Terumo Corporation
10.6.1 Terumo Corporation Company Information
10.6.2 Terumo Corporation Introduction and Business Overview
10.6.3 Terumo Corporation Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Terumo Corporation Vascular Stents Products Offered
10.6.5 Terumo Corporation Recent Development
10.7 Microport Scientific Corporation
10.7.1 Microport Scientific Corporation Company Information
10.7.2 Microport Scientific Corporation Introduction and Business Overview
10.7.3 Microport Scientific Corporation Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Microport Scientific Corporation Vascular Stents Products Offered
10.7.5 Microport Scientific Corporation Recent Development
10.8 Meril Life Sciences Pvt. Ltd.
10.8.1 Meril Life Sciences Pvt. Ltd. Company Information
10.8.2 Meril Life Sciences Pvt. Ltd. Introduction and Business Overview
10.8.3 Meril Life Sciences Pvt. Ltd. Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Meril Life Sciences Pvt. Ltd. Vascular Stents Products Offered
10.8.5 Meril Life Sciences Pvt. Ltd. Recent Development
10.9 Vascular Concepts Limited
10.9.1 Vascular Concepts Limited Company Information
10.9.2 Vascular Concepts Limited Introduction and Business Overview
10.9.3 Vascular Concepts Limited Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Vascular Concepts Limited Vascular Stents Products Offered
10.9.5 Vascular Concepts Limited Recent Development
10.10 C.R. Bard, Inc.
10.10.1 C.R. Bard, Inc. Company Information
10.10.2 C.R. Bard, Inc. Introduction and Business Overview
10.10.3 C.R. Bard, Inc. Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.10.4 C.R. Bard, Inc. Vascular Stents Products Offered
10.10.5 C.R. Bard, Inc. Recent Development
10.11 W.L. Gore and Associates, Inc.
10.11.1 W.L. Gore and Associates, Inc. Company Information
10.11.2 W.L. Gore and Associates, Inc. Introduction and Business Overview
10.11.3 W.L. Gore and Associates, Inc. Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.11.4 W.L. Gore and Associates, Inc. Vascular Stents Products Offered
10.11.5 W.L. Gore and Associates, Inc. Recent Development
10.12 Endologix, Inc.
10.12.1 Endologix, Inc. Company Information
10.12.2 Endologix, Inc. Introduction and Business Overview
10.12.3 Endologix, Inc. Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Endologix, Inc. Vascular Stents Products Offered
10.12.5 Endologix, Inc. Recent Development
10.13 Lombard Medical
10.13.1 Lombard Medical Company Information
10.13.2 Lombard Medical Introduction and Business Overview
10.13.3 Lombard Medical Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Lombard Medical Vascular Stents Products Offered
10.13.5 Lombard Medical Recent Development
10.14 Translumina Gmbh
10.14.1 Translumina Gmbh Company Information
10.14.2 Translumina Gmbh Introduction and Business Overview
10.14.3 Translumina Gmbh Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Translumina Gmbh Vascular Stents Products Offered
10.14.5 Translumina Gmbh Recent Development
10.15 Jotec Gmbh
10.15.1 Jotec Gmbh Company Information
10.15.2 Jotec Gmbh Introduction and Business Overview
10.15.3 Jotec Gmbh Vascular Stents Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Jotec Gmbh Vascular Stents Products Offered
10.15.5 Jotec Gmbh Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vascular Stents Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vascular Stents Industrial Chain Analysis
11.4 Vascular Stents Market Dynamics
11.4.1 Vascular Stents Industry Trends
11.4.2 Vascular Stents Market Drivers
11.4.3 Vascular Stents Market Challenges
11.4.4 Vascular Stents Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vascular Stents Distributors
12.3 Vascular Stents Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
